Pharmacy

TrialGPT could help providers navigate the vast and ever-changing range of clinical trials available to their patients by finding, ranking and explaining why a patient is matched, the agency says.

A pilot validation study found that the AI helped hasten case reviews and data analysis and determine the necessity of antibiotic use.

The third extension of pandemic-era telehealth flexibilities through the end of next year will give the agencies time to promulgate final regulations and providers time to comply, the agencies said.

The group expects support for virtual care to continue after the 2024 election, but urges action as soon as possible to extend pandemic-era telehealth flexibilities past the end of the year.

Insured customers paid more for drugs than members of its Prescription Savings Club, lawsuit alleges.

OpenAI's GPT-4 and Google's Gemini did not recommend opioid medication for one group over another – suggesting that artificial intelligence could help address clinician bias and improve fairness in treating pain.

AlphaProteo was created to advance drug design and disease understanding by helping researchers configure high-strength proteins that bind to molecules.

Anne Moen of Gravitate-Health says the company wants to work with regulators to help European patients translate prescription information into their language of choice while traveling through the EU.

QuantHealth helps pharma implement artificial intelligence for drug development using clinical trial simulation. Orr Inbar, its cofounder and CEO, discusses that — and the long-term effects of AI on drug development.

Also: Pfizer says it is partnering with healthcare organizations to develop a new digital health platform that provides access to same-day care, prescriptions and vaccines for COVID-19 or the flu.